SHENZHEN, China, Dec. 29, 2015 /PRNewswire/ -- Mindray
Medical International Limited ("Mindray", NYSE: MR), a leading
developer, manufacturer and marketer of medical devices
worldwide, today announced shareholder resolutions adopted at
its annual general meeting of shareholders held in Hong Kong on December 28, 2015.
At the meeting, Mindray shareholders voted to re-elect incumbent
director, chairman of board Xu Hang
and director Ronald Ede, each to
serve a three-year term.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company's independent registered
public accounting firm for the fiscal year ending December 31,
2015.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain our global headquarters in
Shenzhen, China, U.S. headquarters
in Mahwah, New Jersey and multiple
sales offices in major international markets. From our main
manufacturing and engineering base in China, we supply through our worldwide
distribution network a broad range of products across three primary
business segments, namely patient monitoring and life support,
in-vitro diagnostic, and medical imaging systems. For more
information, please visit http://ir.mindray.com.
For investor and media inquiries, please contact:
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
In the U.S.:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mindray-announced-shareholder-resolutions-post-2015-annual-general-meeting-300197513.html
SOURCE Mindray Medical International Limited